KRITINUT

Kriti Nutrients Share Price

₹116.60 -6.1 (-4.97%)

14 Nov, 2024 23:33

SIP TrendupStart SIP in KRITINUT

Start SIP

Performance

  • Low
  • ₹117
  • High
  • ₹122
  • 52 Week Low
  • ₹69
  • 52 Week High
  • ₹167
  • Open Price₹117
  • Previous Close₹123
  • Volume39,717

Investment Returns

  • Over 1 Month -18.29%
  • Over 3 Month -5.36%
  • Over 6 Month + 14.31%
  • Over 1 Year + 61.5%
SIP Lightning

Smart Investing Starts Here Start SIP with Kriti Nutrients for Steady Growth!

Invest Now

Kriti Nutrients Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 12.5
  • PEG Ratio
  • 0.4
  • Market Cap Cr
  • 584
  • P/B Ratio
  • 3.3
  • Average True Range
  • 7.36
  • EPS
  • 9.34
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -0.93
  • RSI
  • 31.88
  • MFI
  • 41.66

Kriti Nutrients Financials

Kriti Nutrients Technicals

EMA & SMA

Current Price
₹116.60
-6.1 (-4.97%)
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹136.23
  • 50 Day
  • ₹137.49
  • 100 Day
  • ₹132.51
  • 200 Day
  • ₹120.67

Resistance and Support

117.1 Pivot Speed
  • R3 118.95
  • R2 118.45
  • R1 117.60
  • S1 116.25
  • S2 115.75
  • S3 114.90

What's your outlook on Kriti Nutrients?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Kriti Nutrients Ltd manufactures and markets a range of agricultural products, including fertilizers and micronutrients. Committed to sustainable farming practices, the company serves farmers across India, enhancing crop yields and soil health through quality nutrient solutions.

Kriti Nutrients has an operating revenue of Rs. 700.44 Cr. on a trailing 12-month basis. An annual revenue de-growth of -14% needs improvement, Pre-tax margin of 9% is okay, ROE of 25% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 7% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 96 indicates it belongs to a poor industry group of Food-Misc Preparation and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Kriti Nutrients Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-09 Quarterly Results
2024-08-03 Quarterly Results
2024-05-03 Audited Results & Final Dividend
2024-01-25 Quarterly Results
2023-11-08 Quarterly Results

Kriti Nutrients F&O

Kriti Nutrients Shareholding Pattern

66.68%
0.03%
0%
20.21%
13.08%

About Kriti Nutrients

  • NSE Symbol
  • KRITINUT
  • BSE Symbol
  • 533210
  • Chairman & Managing Director
  • Mr. Shiv Singh Mehta
  • ISIN
  • INE798K01010

Similar Stocks to Kriti Nutrients

Kriti Nutrients FAQs

Kriti Nutrients share price is ₹116 As on 14 November, 2024 | 23:19

The Market Cap of Kriti Nutrients is ₹584.2 Cr As on 14 November, 2024 | 23:19

The P/E ratio of Kriti Nutrients is 12.5 As on 14 November, 2024 | 23:19

The PB ratio of Kriti Nutrients is 3.3 As on 14 November, 2024 | 23:19

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23